Vertex Pharmaceuticals Incorporated vs Wolfspeed Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $478.01 (market cap $121.95B), while Wolfspeed Inc trades at $32.51 (market cap $1.53B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 79.7× Wolfspeed Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, Wolfspeed Inc nearer its low. Which is the better fit depends on your goals.
| VRTX | WOLF | |
|---|---|---|
Market Cap | $121.95B | $1.53B |
Sector | Health | Technology |
52-Week High | $529.59 | $73.68 |
52-Week Low | $366.54 | $1.19 |
Enterprise Value | $116.69B | $2.19B |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Wolfspeed is the global leader in wide bandgap semiconductors, specializing in silicon carbide (SiC) and gallium nitride (GaN) materials and devices. It operates a vertically integrated model, controlling the entire process from raw material substrate production to advanced power modules, serving as a critical infrastructure provider for electric vehicles (EVs), renewable energy, and AI data centers.
Read more on WOLF →